Posted by Michael Wonder on 14 Nov 2016
How to facilitate development of cancer treatment based on genetically modified T-cells
8 November 2016 - Watch live broadcast of expert discussion at EMA.
A workshop on the scientific and regulatory challenges of innovative cancer immunotherapy medicines based on genetically modified T-cells (white blood cells that normally fight off viruses and bacteria) will take place at the EMA on Tuesday and Wednesday, 15-16 November 2016.
You can follow a live broadcast of the workshop by clicking on the 'multimedia' tab on the EMA event page.
The workshop, which is organised by the Agency’s Committee for Advanced Therapies (CAT), aims to facilitate dialogue between the CAT and medicine developers from industry and academia on current scientific developments, regulatory requirements for product manufacture and clinical development of these medicines.
